Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone in Psoriasis
NCT04250792Phase 1Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Jan 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naltrexone in psoriasis, sponsored by Jinnah Postgraduate Medical Centre. Primary endpoints: Psoriasis Area and Severity Index at 12 weeks, Body Surface Area at 12 weeks and 1 more. Started Jan 2019; status: completed.
02
Drugs
naltrexone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04250792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04250792.